Alanine racemase mutants of Burkholderia pseudomallei and Burkholderia mallei and use of Alanine racemase as a non-antibiotic-based selectable marker

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Zajdowicz, Sheryl L W ^a,b   Jones Carson, Jessica ^a   Vazquez Torres, Andres ^a   Jobling, Michael G ^a   Gill, Ronald E ^a   Holmes, Randall K ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b METROPOLITAN STATE UNIVERSITY OF DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE RACEMASE; ALANINE; ANTIINFECTIVE AGENT; PERIODIC ACID;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CELL CYCLE ARREST; CELL VIABILITY; CONTROLLED STUDY; ENZYME DEFICIENCY; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; MICROBIAL ATTENUATION; NONHUMAN; PHAGOCYTOSIS; PLASMID; SEQUENCE ALIGNMENT; ANIMAL; BACTERIAL GENE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENE LOCUS; GENETIC MARKER; GENETICS; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR GENETICS; MOUSE; MUTATION; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; ULTRASTRUCTURE;

BURKHOLDERIA; BURKHOLDERIA MALLEI; BURKHOLDERIA MALLEI ATCC 23344; BURKHOLDERIA PSEUDOMALLEI; ESCHERICHIA COLI; MURINAE;

ALANINE; ALANINE RACEMASE; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; GENE DELETION; GENES, BACTERIAL; GENETIC LOCI; GENETIC MARKERS; MACROPHAGES, PERITONEAL; MICE; MICROBIAL VIABILITY; MOLECULAR SEQUENCE DATA; MUTATION; PERIODIC ACID; PLASMIDS; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SEQUENCE ALIGNMENT;

EID: 79959608390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021523     Document Type: Article

References (62)

1. Gilad J, (2007) Burkholderia mallei and Burkholderia pseudomallei: the causative micro-organisms of glanders and melioidosis. Recent Patents Anti-Infect Drug Disc 2: 233-241.
2. Neubauer H, Sprague LD, Zacharia R, Tomaso H, Al Dahouk S, et al. (2005) Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives. J Vet Med B Infect Dis Vet Public Health 52: 201-205.
3. Whitlock GC, Estes DM, Torres AG, (2007) Glanders: off to the races with Burkholderia mallei. FEMS Microbiol Lett 277: 115-122.
4. Dance DA, (2000) Ecology of Burkholderia pseudomallei and the interactions between environmental Burkholderia spp. and human-animal hosts. Acta Trop 74: 159-168.
5. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416.
6. Limmathurotsakul D, Chaowagul W, Chantratita N, Wuthiekanun V, Biaklang M, et al. (2008) A Simple Scoring System to Differentiate between Relapse and Re-Infection in Patients with Recurrent Melioidosis. PLoS Negl Trop Dis 2: e327.
7. Choi KH, DeShazer D, Schweizer HP, (2006) mini-Tn7 insertion in bacteria with multiple glmS-linked attTn7 sites: example Burkholderia mallei ATCC 23344. Nat Protoc 1: 162-169.
8. Choi KH, Gaynor JB, White KG, Lopez C, Bosio CM, et al. (2005) A Tn7-based broad-range bacterial cloning and expression system. Nat Methods 2: 443-448.
9. Choi KH, Mima T, Casart Y, Rholl D, Kumar A, et al. (2008) Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei. Appl Environ Microbiol 74: 1064-1075.
10. DeShazer D, Brett PJ, Carlyon R, Woods DE, (1997) Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene. J Bacteriol 179: 2116-2125.
11. Thongdee M, Gallagher LA, Schell M, Dharakul T, Songsivilai S, et al. (2008) Targeted mutagenesis of Burkholderia thailandensis and Burkholderia pseudomallei through natural transformation of PCR fragments. Appl Environ Microbiol 74: 2985-2989.
12. Hamad MA, Zajdowicz SL, Holmes RK, Voskuil MI, (2009) An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene 430: 123-131.
13. Ruhland GJ, Fiedler F, (1987) Occurrence and biochemistry of lipoteichoic acids in the genus Listeria. Syst Appl Microbiol 9: 40-46.
14. Fischer W, (1990) Bacterial phopholipids and lipoteichoic acids. In: Kates M, editors. Glycolipids, phosphoglycolipids, and sulfoglycolipids New York, N. Y. Plenum Press pp. 123-234.
15. Wijsman HJ, (1972) The characterization of an alanine racemase mutant of Escherichia coli. Genet Res 20: 269-277.
16. Thompson RJ, Bouwer HG, Portnoy DA, Frankel FR, (1998) Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires d-alanine for growth. Infect Immun 66: 3552-3561.
17. Milligan DL, Tran SL, Strych U, Cook GM, Krause KL, (2007) The alanine racemase of Mycobacterium smegmatis is essential for growth in the absence of d-alanine. J Bacteriol 189: 8381-8386.
18. Rosso G, Takashima K, Adams E, (1969) Coenzyme content of purified alanine racemase from Pseudomonas. Biochem Biophys Res Commun 34: 134-140.
19. Wasserman SA, Walsh CT, Botstein D, (1983) Two alanine racemase genes in Salmonella typhimurium that differ in structure and function. J Bacteriol 153: 1439-1450.
20. Tauch A, Gotker S, Puhler A, Kalinowski J, Thierbach G, (2002) The alanine racemase gene alr is an alternative to antibiotic resistance genes in cloning systems for industrial Corynebacterium glutamicum strains. J Biotechnol 99: 79-91.
21. Oikawa T, Tauch A, Schaffer S, Fujioka T, (2006) Expression of alr gene from Corynebacterium glutamicum ATCC 13032 in Escherichia coli and molecular characterization of the recombinant alanine racemase. J Biotechnol 125: 503-512.
22. Hols P, Defrenne C, Ferain T, Derzelle S, Delplace B, et al. (1997) The alanine racemase gene is essential for growth of Lactobacillus plantarum. J Bacteriol 179: 3804-3807.
23. Inagaki K, Tanizawa K, Badet B, Walsh CT, Tanaka H, et al. (1986) Thermostable alanine racemase from Bacillus stearothermophilus: molecular cloning of the gene, enzyme purification, and characterization. Biochemistry 25: 3268-3274.
24. Ferrari E, Henner DJ, Yang MY, (1985) Isolation of an alanine racemase from Bacillus subtilis and its use for plasmid maintenance in B. subtilis. Bio/Technology 3: 1003-1007.
25. Preston RA, Douthit HA, (1984) Germination of Bacillus cereus spores: critical control by dl-alanine racemase. J Gen Microbiol 130: 3123-3133.
26. Yonaha K, Yorifuji T, Yamamoto I, Soda K, (1975) Alanine racemase of Bacillus subtilis var. atterimus. J Ferment Technol 53: 579-587.
27. Strych U, Benedik MJ, (2002) Mutant analysis shows that alanine racemases from Pseudomonas aeruginosa and Escherichia coli are dimeric. J Bacteriol 184: 4321-4325.
28. Strych U, Davlieva M, Longtin JP, Murphy EL, Im H, et al. (2007) Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae. BMC Microbiol 7: 40.
29. Strych U, Huang HC, Krause KL, Benedik MJ, (2000) Characterization of the alanine racemases from Pseudomonas aeruginosa PAO1. Curr Microbiol 41: 290-294.
30. Strych U, Penland RL, Jimenez M, Krause KL, Benedik MJ, (2001) Characterization of the alanine racemases from two mycobacteria. FEMS Microbiol Lett 196: 93-98.
31. Wild J, Hennig J, Lobocka M, Walczak W, Klopotowski T, (1985) Identification of the dadX gene coding for the predominant isozyme of alanine racemase in Escherichia coli K12. Mol Gen Genet 198: 315-322.
32. Bron PA, Benchimol MG, Lambert J, Palumbo E, Deghorain M, et al. (2002) Use of the alr gene as a food-grade selection marker in lactic acid bacteria. Appl Environ Microbiol 68: 5663-5670.
33. Verch T, Pan ZK, Paterson Y, (2004) Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines. Infect Immun 72: 6418-6425.
34. Lenz LL, Huang WA, Zhou C, Li Z, Calendar R, (2008) Stable integration vector for nutrient broth-based selection of attenuated Listeria monocytogenes strains with recombinant antigen expression. Clin Vaccine Immunol 15: 1414-1419.
35. Holden MT, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Atkins T, et al. (2004) Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 101: 14240-14245.
36. Nierman WC, DeShazer D, Kim HS, Tettelin H, Nelson KE, et al. (2004) Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci U S A 101: 14246-14251.
37. Durfee T, Nelson R, Baldwin S, Plunkett G 3rd, Burland V, et al. (2008) The complete genome sequence of Escherichia coli DH10B: insights into the biology of a laboratory workhorse. J Bacteriol 190: 2597-2606.
38. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964.
39. Kim HS, Schell MA, Yu Y, Ulrich RL, Sarria SH, et al. (2005) Bacterial genome adaptation to niches: divergence of the potential virulence genes in three Burkholderia species of different survival strategies. BMC Genomics 6: 174.
40. Jones AL, Beveridge TJ, Woods DE, (1996) Intracellular survival of Burkholderia pseudomallei. Infect Immun 64: 782-790.
41. DeShazer D, Waag DM, (2004) Glanders: new insights into an old disease. In: Lindler L, Lebeda F, Korch GW, editors. Biological weapons defense: Infectious diseases and counterbioterrorism Totowa, N. J. The Humana Press, Inc pp. 209-237.
42. Leelarasamee A, (1998) Burkholderia pseudomallei: the unbeatable foe? Southeast Asian J Trop Med Public Health 29: 410-415.
43. Ross P, O'Gara F, Condon S, (1990) Thymidylate synthase gene from Lactococcus lactis as a genetic marker: an alternative to antibiotic resistance genes. Appl Environ Microbiol 56: 2164-2169.
44. Ross P, O'Gara F, Condon S, (1990) Cloning and characterization of the thymidylate synthase gene from Lactococcus lactis subsp. lactis. Appl Environ Microbiol 56: 2156-2163.
45. Galan JE, Nakayama K, Curtiss R 3rd, (1990) Cloning and characterization of the asd gene of Salmonella typhimurium: use in stable maintenance of recombinant plasmids in Salmonella vaccine strains. Gene 94: 29-35.
46. Handfield M, Schweizer HP, Mahan MJ, Sanschagrin F, Hoang T, et al. (1998) ASD-GFP vectors for in vivo expression technology in Pseudomonas aeruginosa and other gram-negative bacteria. Biotechniques 24: 261-264.
47. Walsh CT, (1989) Enzymes in the d-alanine branch of bacterial cell wall peptidoglycan assembly. J Biol Chem 264: 2393-2396.
48. Wasserman SA, Daub E, Grisafi P, Botstein D, Walsh CT, (1984) Catabolic alanine racemase from Salmonella typhimurium: DNA sequence, enzyme purification, and characterization. Biochemistry 23: 5182-5187.
49. Reitzer LJ, (1996) Ammonia assimilation and the biosynthesis of glutamine, glutamate, aspartate, asparagine, l-alanine, and d-alanine. In: Neidhardt FC, Curtiss R, editors. E coli and Salmonella: cellular and molecular biology Washington, DC ASM Press pp. 391-407.
50. Hamase K, Homma H, Takigawa Y, Fukushima T, Santa T, et al. (1997) Regional distribution and postnatal changes of d-amino acids in rat brain. Biochim Biophys Acta 1334: 214-222.
51. Hamase K, Homma H, Takigawa Y, Imai K, (1999) Alteration in the d-amino acid content of the rat pineal gland under anesthesia. Amino Acids 17: 277-283.
52. Hashimoto A, Nishikawa T, Konno R, Niwa A, Yasumura Y, et al. (1993) Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase. Neurosci Lett 152: 33-36.
53. Nagata Y, Masui R, Akino T, (1992) The presence of free d-serine, d-alanine and d-proline in human plasma. Experientia 48: 986-988.
54. Nagata Y, Yamamoto K, Shimojo T, Konno R, Yasumura Y, et al. (1992) The presence of free d-alanine, d-proline and d-serine in mice. Biochim Biophys Acta 1115: 208-211.
55. Propst KL, Mima T, Choi KH, Dow SW, Schweizer HP, (2010) A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists. Infect Immun 78: 3136-3143.
56. Cherepanov PP, Wackernagel W, (1995) Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158: 9-14.
57. Ausubel FM, Brent RE, Kingston DD, Moore JG, Seidman JG, et al. (2002) Short protocols in molecular biology New York, NY John Wiley & Sons.
58. Figurski DH, Helinski DR, (1979) Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76: 1648-1652.
59. Vazquez-Torres A, Jones-Carson J, Mastroeni P, Ischiropoulos H, Fang FC, (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J Exp Med 192: 227-236.
60. Stevens JM, Ulrich RL, Taylor LA, Wood MW, Deshazer D, et al. (2005) Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J Bacteriol 187: 7857-7862.
61. McCollister BD, Bourret TJ, Gill R, Jones-Carson J, Vazquez-Torres A, (2005) Repression of SPI2 transcription by nitric oxide-producing, IFNgamma-activated macrophages promotes maturation of Salmonella phagosomes. J Exp Med 202: 625-635.
62. Yabuuchi E, Kosako Y, Oyaizu H, Yano I, Hotta H, et al. (1992) Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol 36: 1251-1275.